A 6 day course of liposomal amphotericin B in the treatment of infantile visceral leishmaniasis

The Italian experience

Antonio Cascio, Lucio di Martino, Paolo Occorsio, Raffaella Giacchino, Salvatore Catania, Anna Rita Gigliotti, Camilla Aiassa, Chiara Iaria, Salvatore Giordano, Claudia Colomba, Valentina Frasca Polara, Lucina Titone, Luigi Gradoni, Marina Gramiccia, Spinello Antinori

Research output: Contribution to journalArticle

28 Citations (Scopus)

Abstract

Objectives: To evaluate in a retrospective analysis the efficacy and safety of a 6 day course of liposomal amphotericin B (L-AmB) in infantile cases of Mediterranean visceral leishmaniasis (VL) diagnosed over a 10 year period in Italy. Patients and methods: Patients included were diagnosed as having VL consecutively admitted from December 1992 to December 2001 at four main referral children's hospitals in Italy and treated with six intravenous doses of 3 mg/kg L-AmB given on days 1-5 and 10 (a total dose of 18 mg/kg). Demographic data, nutritional status, underlying diseases, clinical and laboratory findings, and therapy outcome were considered. Results: A total of 164 HIV-negative children (median age 1.6 years; range 4 months to 14 years) were enrolled. All patients were initially cured by the given treatment, and did not present adverse events related to drug infusion. Seven patients (4.3%) had a clinical and parasitological relapse 3-15 months after therapy. All relapses were successfully retreated with 3 mg/kg L-AmB for 10 consecutive days (a total dose of 30 mg/kg). Conclusions: This study highlights the efficacy (>95%) and safety of the six dose L-AmB regimen and validates it as a first-line treatment for Mediterranean VL in children.

Original languageEnglish
Pages (from-to)217-220
Number of pages4
JournalJournal of Antimicrobial Chemotherapy
Volume54
Issue number1
DOIs
Publication statusPublished - Jul 2004

Fingerprint

Visceral Leishmaniasis
Italy
Safety
Recurrence
Therapeutics
Nutritional Status
Referral and Consultation
Demography
HIV
liposomal amphotericin B
Pharmaceutical Preparations

Keywords

  • Italy
  • Leishmania infantum
  • Therapy

ASJC Scopus subject areas

  • Pharmacology
  • Microbiology

Cite this

Cascio, A., di Martino, L., Occorsio, P., Giacchino, R., Catania, S., Gigliotti, A. R., ... Antinori, S. (2004). A 6 day course of liposomal amphotericin B in the treatment of infantile visceral leishmaniasis: The Italian experience. Journal of Antimicrobial Chemotherapy, 54(1), 217-220. https://doi.org/10.1093/jac/dkh279

A 6 day course of liposomal amphotericin B in the treatment of infantile visceral leishmaniasis : The Italian experience. / Cascio, Antonio; di Martino, Lucio; Occorsio, Paolo; Giacchino, Raffaella; Catania, Salvatore; Gigliotti, Anna Rita; Aiassa, Camilla; Iaria, Chiara; Giordano, Salvatore; Colomba, Claudia; Polara, Valentina Frasca; Titone, Lucina; Gradoni, Luigi; Gramiccia, Marina; Antinori, Spinello.

In: Journal of Antimicrobial Chemotherapy, Vol. 54, No. 1, 07.2004, p. 217-220.

Research output: Contribution to journalArticle

Cascio, A, di Martino, L, Occorsio, P, Giacchino, R, Catania, S, Gigliotti, AR, Aiassa, C, Iaria, C, Giordano, S, Colomba, C, Polara, VF, Titone, L, Gradoni, L, Gramiccia, M & Antinori, S 2004, 'A 6 day course of liposomal amphotericin B in the treatment of infantile visceral leishmaniasis: The Italian experience', Journal of Antimicrobial Chemotherapy, vol. 54, no. 1, pp. 217-220. https://doi.org/10.1093/jac/dkh279
Cascio, Antonio ; di Martino, Lucio ; Occorsio, Paolo ; Giacchino, Raffaella ; Catania, Salvatore ; Gigliotti, Anna Rita ; Aiassa, Camilla ; Iaria, Chiara ; Giordano, Salvatore ; Colomba, Claudia ; Polara, Valentina Frasca ; Titone, Lucina ; Gradoni, Luigi ; Gramiccia, Marina ; Antinori, Spinello. / A 6 day course of liposomal amphotericin B in the treatment of infantile visceral leishmaniasis : The Italian experience. In: Journal of Antimicrobial Chemotherapy. 2004 ; Vol. 54, No. 1. pp. 217-220.
@article{399d6fea317c44c988a5d7cb92b97188,
title = "A 6 day course of liposomal amphotericin B in the treatment of infantile visceral leishmaniasis: The Italian experience",
abstract = "Objectives: To evaluate in a retrospective analysis the efficacy and safety of a 6 day course of liposomal amphotericin B (L-AmB) in infantile cases of Mediterranean visceral leishmaniasis (VL) diagnosed over a 10 year period in Italy. Patients and methods: Patients included were diagnosed as having VL consecutively admitted from December 1992 to December 2001 at four main referral children's hospitals in Italy and treated with six intravenous doses of 3 mg/kg L-AmB given on days 1-5 and 10 (a total dose of 18 mg/kg). Demographic data, nutritional status, underlying diseases, clinical and laboratory findings, and therapy outcome were considered. Results: A total of 164 HIV-negative children (median age 1.6 years; range 4 months to 14 years) were enrolled. All patients were initially cured by the given treatment, and did not present adverse events related to drug infusion. Seven patients (4.3{\%}) had a clinical and parasitological relapse 3-15 months after therapy. All relapses were successfully retreated with 3 mg/kg L-AmB for 10 consecutive days (a total dose of 30 mg/kg). Conclusions: This study highlights the efficacy (>95{\%}) and safety of the six dose L-AmB regimen and validates it as a first-line treatment for Mediterranean VL in children.",
keywords = "Italy, Leishmania infantum, Therapy",
author = "Antonio Cascio and {di Martino}, Lucio and Paolo Occorsio and Raffaella Giacchino and Salvatore Catania and Gigliotti, {Anna Rita} and Camilla Aiassa and Chiara Iaria and Salvatore Giordano and Claudia Colomba and Polara, {Valentina Frasca} and Lucina Titone and Luigi Gradoni and Marina Gramiccia and Spinello Antinori",
year = "2004",
month = "7",
doi = "10.1093/jac/dkh279",
language = "English",
volume = "54",
pages = "217--220",
journal = "Journal of Antimicrobial Chemotherapy",
issn = "0305-7453",
publisher = "Oxford University Press",
number = "1",

}

TY - JOUR

T1 - A 6 day course of liposomal amphotericin B in the treatment of infantile visceral leishmaniasis

T2 - The Italian experience

AU - Cascio, Antonio

AU - di Martino, Lucio

AU - Occorsio, Paolo

AU - Giacchino, Raffaella

AU - Catania, Salvatore

AU - Gigliotti, Anna Rita

AU - Aiassa, Camilla

AU - Iaria, Chiara

AU - Giordano, Salvatore

AU - Colomba, Claudia

AU - Polara, Valentina Frasca

AU - Titone, Lucina

AU - Gradoni, Luigi

AU - Gramiccia, Marina

AU - Antinori, Spinello

PY - 2004/7

Y1 - 2004/7

N2 - Objectives: To evaluate in a retrospective analysis the efficacy and safety of a 6 day course of liposomal amphotericin B (L-AmB) in infantile cases of Mediterranean visceral leishmaniasis (VL) diagnosed over a 10 year period in Italy. Patients and methods: Patients included were diagnosed as having VL consecutively admitted from December 1992 to December 2001 at four main referral children's hospitals in Italy and treated with six intravenous doses of 3 mg/kg L-AmB given on days 1-5 and 10 (a total dose of 18 mg/kg). Demographic data, nutritional status, underlying diseases, clinical and laboratory findings, and therapy outcome were considered. Results: A total of 164 HIV-negative children (median age 1.6 years; range 4 months to 14 years) were enrolled. All patients were initially cured by the given treatment, and did not present adverse events related to drug infusion. Seven patients (4.3%) had a clinical and parasitological relapse 3-15 months after therapy. All relapses were successfully retreated with 3 mg/kg L-AmB for 10 consecutive days (a total dose of 30 mg/kg). Conclusions: This study highlights the efficacy (>95%) and safety of the six dose L-AmB regimen and validates it as a first-line treatment for Mediterranean VL in children.

AB - Objectives: To evaluate in a retrospective analysis the efficacy and safety of a 6 day course of liposomal amphotericin B (L-AmB) in infantile cases of Mediterranean visceral leishmaniasis (VL) diagnosed over a 10 year period in Italy. Patients and methods: Patients included were diagnosed as having VL consecutively admitted from December 1992 to December 2001 at four main referral children's hospitals in Italy and treated with six intravenous doses of 3 mg/kg L-AmB given on days 1-5 and 10 (a total dose of 18 mg/kg). Demographic data, nutritional status, underlying diseases, clinical and laboratory findings, and therapy outcome were considered. Results: A total of 164 HIV-negative children (median age 1.6 years; range 4 months to 14 years) were enrolled. All patients were initially cured by the given treatment, and did not present adverse events related to drug infusion. Seven patients (4.3%) had a clinical and parasitological relapse 3-15 months after therapy. All relapses were successfully retreated with 3 mg/kg L-AmB for 10 consecutive days (a total dose of 30 mg/kg). Conclusions: This study highlights the efficacy (>95%) and safety of the six dose L-AmB regimen and validates it as a first-line treatment for Mediterranean VL in children.

KW - Italy

KW - Leishmania infantum

KW - Therapy

UR - http://www.scopus.com/inward/record.url?scp=3543062878&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=3543062878&partnerID=8YFLogxK

U2 - 10.1093/jac/dkh279

DO - 10.1093/jac/dkh279

M3 - Article

VL - 54

SP - 217

EP - 220

JO - Journal of Antimicrobial Chemotherapy

JF - Journal of Antimicrobial Chemotherapy

SN - 0305-7453

IS - 1

ER -